Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Orly Vardeny

Showing results (61-70 of 168) with videos related to

Pageof 17
Sort By:
Journal of the American College of Cardiology|June 18, 2025
Heart Failure With Improved Ejection Fraction: Definitions, Epidemiology, and ManagementMauro Riccardi, Maria A Pabon, Ankeet S Bhatt, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 21, 2021
Resistance to antihypertensive treatment and long-term risk: The Atherosclerosis Risk in Communities studyMagnus O Wijkman, Marcus V B Malachias, Brian L Claggett, et al.
Journal of the American College of Cardiology|October 9, 2020
Influenza Vaccination to Reduce Cardiovascular Morbidity and Mortality in Patients With COVID-19: JACC State-of-the-Art ReviewBahar Behrouzi, Maria Viviana Araujo Campoverde, Kyle Liang, et al.
Circulation|January 7, 2020
Recognition and Initial Management of Fulminant Myocarditis: A Scientific Statement From the American Heart AssociationRobb D Kociol, Leslie T Cooper, James C Fang, et al.
JAMA Cardiology|November 15, 2016
Reduced Risk of Hyperkalemia During Treatment of Heart Failure With Mineralocorticoid Receptor Antagonists by Use of Sacubitril/Valsartan Compared With Enalapril: A Secondary Analysis of the PARADIGM-HF TrialAkshay S Desai, Orly Vardeny, Brian Claggett, et al.
Circulation|June 18, 2026
Strategies for Optimizing Heart Failure Care in the Older Adult: A Scientific Statement From the American Heart AssociationSabra C Lewsey, Trejeeve Martyn, Vanessa Blumer, et al.
JACC. Heart Failure|January 10, 2016
Influenza Vaccination in Patients With Chronic Heart Failure: The PARADIGM-HF TrialOrly Vardeny, Brian Claggett, Jacob A Udell, et al.
European Journal of Heart Failure|February 12, 2019
Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM-HF trialOrly Vardeny, Brian Claggett, Jessica Kachadourian, et al.
Pharmacotherapy|December 31, 2008
High-impact articles related to the management of heart failure: 2008 updateCynthia A Jackevicius, Robert L Page, Sheryl Chow, et al.
European Journal of Heart Failure|June 11, 2016
Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trialOrly Vardeny, Brian Claggett, Milton Packer, et al.
Pageof 17

Showing results (61-70 of 168) with videos related to

Sort By:
Pageof 17
Journal of the American College of Cardiology|June 18, 2025
Heart Failure With Improved Ejection Fraction: Definitions, Epidemiology, and ManagementMauro Riccardi, Maria A Pabon, Ankeet S Bhatt, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 21, 2021
Resistance to antihypertensive treatment and long-term risk: The Atherosclerosis Risk in Communities studyMagnus O Wijkman, Marcus V B Malachias, Brian L Claggett, et al.
Journal of the American College of Cardiology|October 9, 2020
Influenza Vaccination to Reduce Cardiovascular Morbidity and Mortality in Patients With COVID-19: JACC State-of-the-Art ReviewBahar Behrouzi, Maria Viviana Araujo Campoverde, Kyle Liang, et al.
Circulation|January 7, 2020
Recognition and Initial Management of Fulminant Myocarditis: A Scientific Statement From the American Heart AssociationRobb D Kociol, Leslie T Cooper, James C Fang, et al.
JAMA Cardiology|November 15, 2016
Reduced Risk of Hyperkalemia During Treatment of Heart Failure With Mineralocorticoid Receptor Antagonists by Use of Sacubitril/Valsartan Compared With Enalapril: A Secondary Analysis of the PARADIGM-HF TrialAkshay S Desai, Orly Vardeny, Brian Claggett, et al.
Circulation|June 18, 2026
Strategies for Optimizing Heart Failure Care in the Older Adult: A Scientific Statement From the American Heart AssociationSabra C Lewsey, Trejeeve Martyn, Vanessa Blumer, et al.
JACC. Heart Failure|January 10, 2016
Influenza Vaccination in Patients With Chronic Heart Failure: The PARADIGM-HF TrialOrly Vardeny, Brian Claggett, Jacob A Udell, et al.
European Journal of Heart Failure|February 12, 2019
Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM-HF trialOrly Vardeny, Brian Claggett, Jessica Kachadourian, et al.
Pharmacotherapy|December 31, 2008
High-impact articles related to the management of heart failure: 2008 updateCynthia A Jackevicius, Robert L Page, Sheryl Chow, et al.
European Journal of Heart Failure|June 11, 2016
Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trialOrly Vardeny, Brian Claggett, Milton Packer, et al.
Pageof 17